Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

Published by The Insight Partners Product code 928798
Published Content info 198 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
Published: February 27, 2020 Content info: 198 Pages
Description

North America, the colorectal cancer market, is anticipated to reach US$ 10,655.1 Mn in 2027 from US$ 7,691.4 Mn in 2019. The market is projected to grow with a CAGR of 4.2% from 2020-2027.

The colorectal cancer market is growing primarily due to the increasing prevalence of colorectal cancer, new product launches, and benefits offered by generic drugs that are boosting the market over the years. Restraining factors, such as pricing pressure on drug manufacturers, are likely to damage the growth of the market in the coming years. On the other hand, growing R&D expenditure for cancer research is expected to have a positive impact on the growth of the North American colorectal cancer market in the coming years.

Colorectal cancer is also known as colon cancer, bowel cancer, or rectal cancer. This type of cancer is the second leading cause of death in women and third in men. Colorectal cancer may be benign, or non-cancerous, or malignant. The symptoms shown by the patients who have colon cancer include changes in bowel habits, diarrhea or constipation, blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.

Colorectal cancer is one of the commonly found and lethal cancers which is developed in an individual with the combined influence of genetic and environmental factors. Additionally, according to the World Health Organization (WHO), colorectal cancer was the third most prevalent form of cancers, with approximately 1.80 million cases around the world in 2018, excluding skin cancer. The rates of colorectal cancer mortality and incidence vary across the globe as per the reports by WHO's cancer database GLOBOCAN. The GLOBOCAN reports approximately 861,000 deaths in 2018 due to colorectal cancer. The data released by the Canadian Cancer Society in 2019, around 1 in 14 Canadian men will be diagnosed with colorectal cancer during their lifetime, and 1 in 18 Canadian women will be diagnosed with colorectal cancer during their lifetime and. Thus, the rising number of patients suffering from the disease is likely to drive the growth of colorectal cancer during the forecast period.

In 2019, the diagnosis type accounted for the largest market share in the North American colorectal cancer market. The growth of diagnosis type is expected to grow due to rising colorectal screening programs and initiatives across the world. The diagnosis type segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development that is enabling the early detection of colorectal cancer by the various method of screenings.

In 2019, the hospitals segment held the most significant market share of the colorectal cancer market by the end user. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the need for hospitals as primary healthcare centers for the people. The segment is also anticipated to witness growth at a significant rate during the forecast period.

Some of the significant primary and secondary sources for colorectal cancer included in the report are World Health Organization (WHO), Food and Drug Administration (FDA), Canadian Cancer Society, Centers for Disease Control and Prevention (CDC), American Cancer Society and others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America colorectal cancer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00009241

Table of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America colorectal cancer Market - By Modality
    • 1.3.2 North America colorectal cancer Market - By End User
    • 1.3.3 North America colorectal cancer Market - By Country

2. North America Colorectal Cancer Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Colorectal Cancer Market - Market Landscape

  • 4.1 overview
  • 4.2 PEST Analysis
    • 4.2.1 Colorectal Cancer Market - North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Colorectal Cancer Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence Of Colorectal Cancer
    • 5.1.2 New Product Launches
    • 5.1.3 Benefits Offered By Generic Drugs
  • 5.2 Key Restraints
    • 5.2.1 Pricing Pressure On Drug Manufacturers
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing R&D Expenditure for Cancer Research
  • 5.4 Future Trend
    • 5.4.1 Inclination Towards Personalized Medicine
  • 5.5 Impact Analysis

6. Colorectal Cancer Market - North America Analysis

  • 6.1 North America Colorectal Cancer Market Revenue Forecasts and Analysis
  • 6.2 Positioning Of Key Players

7. North America Colorectal Cancer Market Analysis And Forecasts To 2027 - Modality

  • 7.1 Overview
  • 7.2 North America Colorectal Cancer Market, By Modality 2018 & 2027 (%)
    • 7.2.1 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 7.2.1.1 North America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 7.2.1.2 North America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 7.2.1.2.1 North America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 7.2.1.2.2 North America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 7.2.1.3 North America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • 7.3 Diagnosis Type Market
    • 7.3.1 Overview
    • 7.3.2 North America Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.3 Immunohistochemistry Market
      • 7.3.3.1 Overview
      • 7.3.3.2 North America Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.4 Stool Test Market
      • 7.3.4.1 Overview
      • 7.3.4.2 North America Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.5 Flexible Sigmoidoscopy Market
      • 7.3.5.1 Overview
      • 7.3.5.2 North America Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.6 Colonoscopy Market
      • 7.3.6.1 Overview
      • 7.3.6.2 North America Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.7 CEA Test Market
      • 7.3.7.1 Overview
      • 7.3.7.2 North America CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.8 Other Test Market
      • 7.3.8.1 Overview
      • 7.3.8.2 North America Other Test Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Therapy Type Market
    • 7.4.1 Overview
    • 7.4.2 North America Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Chemotherapy Market
      • 7.4.3.1 Overview
      • 7.4.3.2 North America Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.3 Alkylating Agent Market
        • 7.4.3.3.1 Overview
        • 7.4.3.3.2 North America Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.4 Antimetabolites Market
        • 7.4.3.4.1 North America Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.5 Others Market
        • 7.4.3.5.1 North America Others Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.4 Immunotherapy Market
      • 7.4.4.1 Overview
      • 7.4.4.2 North America Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.3 Panitumumab Market
        • 7.4.4.3.1 Overview
        • 7.4.4.3.2 North America Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.4 Cetuximab Market
        • 7.4.4.4.1 Overview
        • 7.4.4.4.2 North America Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.5 Bevacizumab Market
        • 7.4.4.5.1 Overview
        • 7.4.4.5.2 North America Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.6 Others Market
        • 7.4.4.6.1 Overview
        • 7.4.4.6.2 North America Others Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.5 Chemoprotectant Market
      • 7.4.5.1 Overview
      • 7.4.5.2 North America Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.6 Others Market
      • 7.4.6.1 Overview
      • 7.4.6.2 North America Others Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Imaging Type Market
    • 7.5.1 Overview
    • 7.5.2 North America Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.5.3 Computed Tomography (CT) Market
      • 7.5.3.1 Overview
      • 7.5.3.2 North America Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.5.4 Magnetic Resonance Imaging (MRI) Market
      • 7.5.4.1 Overview
      • 7.5.4.2 North America Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.5.5 Others Market
      • 7.5.5.1 Overview
      • 7.5.5.2 North America Others Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Colorectal Cancer Market Analysis- By End User

  • 8.1 Overview
  • 8.2 North America Colorectal Cancer Market, By End User 2018 & 2027 (%)
    • 8.2.1 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 8.3 Hospitals Market
    • 8.3.1 Overview
    • 8.3.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Diagnostic and Research Laboratories Market
    • 8.4.1 Overview
    • 8.4.2 North America Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9. Colorectal Cancer Market Revenue And Forecasts To 2027 - Geographical Analysis

  • 9.1 North America Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.1.1 Overview
    • 9.1.2 North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.3 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.1.3.1 North America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.3.2 North America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.3.2.1 North America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.3.2.2 North America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.3.3 North America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.1.4 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.5 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.1.6 US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.1 US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.2 US Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.6.2.1 US Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2 US Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2.1 US Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2.2 US Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.3 US Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.6.3 US Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.7 Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.2 Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.7.2.1 Canada Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2 Canada Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2.1 Canada Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2.2 Canada Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.3 Canada Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.3 Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.8 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.1 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.2 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.8.2.1 Mexico Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2 Mexico Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2.1 Mexico Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2.2 Mexico Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.3 Mexico Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.8.3 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10. North America Colorectal Cancer Market- Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
  • 10.4 Inorganic Developments
    • 10.4.1 Overview
    • 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019

11. Colorectal Cancer Market-Key Company Profiles

  • 11.1 Epigenomics AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Novigenix SA
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Overview
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Clinical Genomics Technologies Pty Ltd.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 EDP Biotech Corporation
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Volitionrx Limited
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Abbott Laboratories
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Overview
    • 11.6.4 Product Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Amgen Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 Pipeline (Clinical Trials) Portfolio
    • 11.7.6 SWOT Analysis
    • 11.7.7 Key Developments
  • 11.8 F. Hoffmann-La Roche AG
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 Pipeline (Clinical Trials) Portfolio
    • 11.8.6 SWOT Analysis
    • 11.8.7 Key Developments
  • 11.9 Bruker Corporation
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Quest Diagnostics Incorporated
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Natera, Inc.
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Financial Overview
    • 11.11.4 Product Portfolio
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Guardant Health, Inc.
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Financial Overview
    • 11.12.4 Product Portfolio
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 2. North America Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 3. North America Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 4. North America Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 5. North America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 6. North America Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 7. North America Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 8. North America Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 9. North America Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 10. North America Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 11. North America Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 12. North America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 13. North America Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 14. North America Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 15. US Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 16. US Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 17. US Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 18. US Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 19. US Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 20. US Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 21. US Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 22. Canada Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 23. Canada Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 24. Canada Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 25. Canada Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 26. Canada Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 27. Canada Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 28. Canada Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 29. Mexico Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 30. Mexico Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 31. Mexico Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 32. Mexico Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 33. Mexico Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 34. Mexico Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 35. Mexico Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 36. Recent Organic Growth Strategies In The Colorectal Cancer Market
  • Table 37. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
  • Table 38. Glossary of Terms, Colorectal Cancer Market

LIST OF FIGURES

  • Figure 1. Colorectal Cancer Market Segmentation
  • Figure 2. North America Colorectal Cancer Market Overview
  • Figure 3. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
  • Figure 4. US Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 5. North America colorectal cancer Market- Leading Country Markets (US$ Mn)
  • Figure 6. North America colorectal Cancer Market, Industry Landscape
  • Figure 7. Colorectal Cancer Market - North America PEST Analysis
  • Figure 8. Comparison of Brand - Name Drugs and Generic Drugs
  • Figure 9. Colorectal Cancer Market Impact Analysis of Drivers And Restraints
  • Figure 10. North America Colorectal Cancer Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 11. Market Positioning Of Key Player In North America Colorectal Cancer Market
  • Figure 12. North America Colorectal Cancer Market, by Modality 2018 & 2027 (%)
  • Figure 13. North America Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. North America Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 15. North America Stool Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 16. North America Flexible Sigmoidoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 17. North America Colonoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 18. North America CEA Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 19. North America Other Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 20. North America Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. North America Chemotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 22. North America Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 23. North America Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 24. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 25. North America Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 26. North America Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 27. North America Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 28. North America Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 29. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 30. North America Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 31. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 32. North America Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. North America Computed Tomography (CT) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 34. North America Magnetic Resonance Imaging (MRI) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 35. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 36. North America Colorectal Cancer Market, by End User 2018 & 2027 (%)
  • Figure 37. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. North America Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. North America Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 40. North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 42. US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Growth Strategies In The Colorectal Cancer Market, 2016-2019
Back to Top